- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Treatment of Refractory Metastatic Renal Cell Carcinoma.
November 1, 2022
An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma.
October 31, 2022
Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer.
October 28, 2022
Perioperative outcomes of open and robot-assisted partial nephrectomy in patients with moderate to high complexity renal tumors.
October 28, 2022
The Critical Gene Screening to Prevent Chromophobe Cell Renal Carcinoma Metastasis through TCGA and WGCNA.
October 27, 2022
Nephrometry and cumulative morbidity after partial nephrectomy: A standardized assessment of complications in the context of PADUA and R.E.N.A.L. scores.
October 27, 2022
Epigenetics in advanced renal cell carcinoma: potential new targets.
October 25, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma.
October 24, 2022
Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms.
October 24, 2022
A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma.
October 21, 2022
Adjuvant therapy for renal cell carcinoma, finally a new standard?
October 21, 2022
Prognostic value of immune phenotype and PD-L1 status in recurrent or metastatic renal cell carcinoma: an exploratory analysis of the ARCHERY study.
October 20, 2022
Role of 18F-FDG PET/CT for detection of recurrence and metastases in renal cell carcinoma-are we underusing PET/CT?
October 19, 2022
CDCA3 Predicts Poor Prognosis and Affects CD8+ T Cell Infiltration in Renal Cell Carcinoma.
October 19, 2022